Global Restructuring Review - Cross-border restructuring and insolvency legal news, features and events

Austrian drug maker’s restructuring succumbs to coronavirus pandemic

By Cristina Brooks

24 March 2020

An Austrian drugs and medical equipment manufacturer, whose restructuring was being overseen by Stefan Riel, will now enter liquidation after investors pulled out of a capital increase citing the coronavirus pandemic’s impact on sales.

Austrian drug maker’s restructuring succumbs to coronavirus pandemic An assortment of pharmaceutical drugs